搜索
Translational Development Acquisition Corp
TDACU添加自选
11.310USD
0.0000.00%
收盘 07/02, 13:00（美东）报价延迟15分钟
234.63M总市值
--市盈率 TTM
关于 Translational Development Acquisition Corp 公司
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.
Translational Development Acquisition Corp简介
公司代码TDACU
公司名称Translational Development Acquisition Corp
上市日期Dec 23, 2024
CEOHoffman (Michael B)
员工数量- -
证券类型Unit
年结日- -
公司地址52 E 83Rd St.
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编10028
电话14132042769
网址
公司代码TDACU
上市日期Dec 23, 2024
CEOHoffman (Michael B)
Translational Development Acquisition Corp公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
常见问题
Translational Development Acquisition Corp的前五大股东是谁？
Translational Development Acquisition Corp 的前五大股东如下：Mr. Michael B. Hoffman
有多少机构持有Translational Development Acquisition Corp(TDACU)的股份？
截至2026Q1，共有47家机构持有Translational Development Acquisition Corp的股份，合计持有的股份价值约为958.07K，占公司总股份的5.55%。与2025Q4相比，机构持股有所增加，增幅为-14147897.00。